ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
kpt3891
|
1.6K |
481K |
4 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
1.6K
|
481K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
14 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
14
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
2 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
6 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: IIQ and ResearchDx sign USA EXO-NET Services Agreement
|
|
kpt3891
|
16 |
8.1K |
8 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
16
|
8.1K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
17 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
17
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
5 |
10/09/23 |
10/09/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
5
|
|
Charts
|
IPD |
Re:
IPD chart
|
|
kpt3891
|
856 |
365K |
6 |
07/09/23 |
07/09/23 |
Charts
|
856
|
365K
|
6
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: IIQ and ResearchDx sign USA EXO-NET Services Agreement
|
|
kpt3891
|
16 |
8.1K |
4 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
16
|
8.1K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: COMPLETION OF PHASE 2 COVID CLINICAL TRIAL
|
|
kpt3891
|
124 |
43K |
15 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
124
|
43K
|
15
|
|
ASX - By Stock
|
BIT |
Re:
Ann: COMPLETION OF PHASE 2 COVID CLINICAL TRIAL
|
|
kpt3891
|
124 |
43K |
23 |
16/08/23 |
16/08/23 |
ASX - By Stock
|
124
|
43K
|
23
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: EXO-OC PROGRAM COMPLETES SERUM EQUIVALENCE STUDY
|
|
kpt3891
|
13 |
6.3K |
5 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
13
|
6.3K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
kpt3891
|
1.3K |
555K |
28 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
28
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
4 |
03/08/23 |
03/08/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ Investor Briefing
|
|
kpt3891
|
19 |
8.3K |
13 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
19
|
8.3K
|
13
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Notice received under section 203D of the Corporations Act
|
|
kpt3891
|
41 |
12K |
2 |
31/07/23 |
31/07/23 |
ASX - By Stock
|
41
|
12K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
7 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
1 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
8 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
8
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
11 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
11
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
kpt3891
|
5.0K |
1.4M |
7 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
5.0K
|
1.4M
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ and Promega announce Global Joint Marketing Agreement
|
|
kpt3891
|
40 |
19K |
36 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
40
|
19K
|
36
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Excellent Clinical Data for SubB2M/CA15-3 Breast Cancer Test
|
|
kpt3891
|
39 |
16K |
20 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
39
|
16K
|
20
|
|
ASX - By Stock
|
BIT |
Re:
Expeictations from larger holders
|
|
kpt3891
|
62 |
18K |
6 |
08/06/23 |
08/06/23 |
ASX - By Stock
|
62
|
18K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
kpt3891
|
2.0K |
725K |
10 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
2.0K
|
725K
|
10
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Trading Halt
|
|
kpt3891
|
82 |
20K |
7 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
82
|
20K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Commencement Phase 2 Covid-19 Clinical Trial
|
|
kpt3891
|
102 |
27K |
5 |
05/05/23 |
05/05/23 |
ASX - By Stock
|
102
|
27K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Commencement Phase 2 Covid-19 Clinical Trial
|
|
kpt3891
|
102 |
27K |
20 |
04/05/23 |
04/05/23 |
ASX - By Stock
|
102
|
27K
|
20
|
|
ASX - By Stock
|
BIT |
Re:
Take Over Offer is over the cup for sure!
|
|
kpt3891
|
112 |
31K |
18 |
15/04/23 |
15/04/23 |
ASX - By Stock
|
112
|
31K
|
18
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
kpt3891
|
13K |
6.3M |
18 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
13K
|
6.3M
|
18
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
kpt3891
|
229 |
122K |
4 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
229
|
122K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
IIQ General Discussion
|
|
kpt3891
|
229 |
122K |
6 |
03/04/23 |
03/04/23 |
ASX - By Stock
|
229
|
122K
|
6
|
|
ASX - By Stock
|
IPD |
Re:
how many people to get tested...
|
|
kpt3891
|
44 |
15K |
9 |
29/03/23 |
29/03/23 |
ASX - By Stock
|
44
|
15K
|
9
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Follow up to NCCN Guidelines for Breast Cancer ASX Release
|
|
kpt3891
|
70 |
25K |
10 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
70
|
25K
|
10
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Follow up to NCCN Guidelines for Breast Cancer ASX Release
|
|
kpt3891
|
70 |
25K |
6 |
25/03/23 |
25/03/23 |
ASX - By Stock
|
70
|
25K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Chairman's Address and Presentation to AGM
|
|
kpt3891
|
103 |
29K |
4 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
103
|
29K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Chairman's Address and Presentation to AGM
|
|
kpt3891
|
103 |
29K |
15 |
18/11/22 |
18/11/22 |
ASX - By Stock
|
103
|
29K
|
15
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Proposed issue of securities - BIT
|
|
kpt3891
|
112 |
32K |
4 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
112
|
32K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
kpt3891
|
3.2K |
1.0M |
0 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
kpt3891
|
3.2K |
1.0M |
3 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
3.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
kpt3891
|
58 |
15K |
13 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
58
|
15K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
kpt3891
|
58 |
15K |
22 |
24/10/22 |
24/10/22 |
ASX - By Stock
|
58
|
15K
|
22
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
kpt3891
|
2.0K |
725K |
6 |
11/10/22 |
11/10/22 |
ASX - By Stock
|
2.0K
|
725K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Bit225 Covid-19 Human Study Commenced
|
|
kpt3891
|
188 |
57K |
8 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
188
|
57K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Bit225 Covid-19 Human Study Commenced
|
|
kpt3891
|
188 |
57K |
13 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
188
|
57K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Bill Gates &MG Foundation &BIOTRON
|
|
kpt3891
|
294 |
88K |
4 |
04/10/22 |
04/10/22 |
ASX - By Stock
|
294
|
88K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Bill Gates &MG Foundation &BIOTRON
|
|
kpt3891
|
294 |
88K |
8 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
294
|
88K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Bill Gates &MG Foundation &BIOTRON
|
|
kpt3891
|
294 |
88K |
7 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
294
|
88K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
kpt3891
|
2.0K |
725K |
9 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
2.0K
|
725K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
kpt3891
|
2.0K |
725K |
6 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
2.0K
|
725K
|
6
|
|